Available Now!

A Rapid Immunoassay for the Simultaneous Direct Detection and Differential Diagnosis of SARS-CoV-2, Influenza Type A and Type B Antigen 

• Sensitivity and Specificity
     − COVID-19 - Sensitivity 93.9%, Specificity 100%
     − Flu A - Sensitivity 91.4%, Specificity 95.7%
     − Flu B - Sensitivity 87.6%, Specificity 95.9%
• FDA Emergency Use Authorization (EUA)
• Visually read in 15 minutes
• Flocked nasopharyngeal swab for superior specimen collection and patient comfort

CPT COVID-19: 87811QW
FLU A: 87804QW
FLU B: 87804QW-59